Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion type Assertion NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_head.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion wasGeneratedBy ECO_0000203 NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_provenance.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion wasDerivedFrom befree-20150227 NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_provenance.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion SIO_000772 21747904 NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_provenance.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion evidence source_evidence_literature NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_provenance.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion description "[The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_provenance.